ProKidney Corp

General ticker "PROK" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $894.3M

ProKidney Corp follows the US Stock Market performance with the rate: 18.8%.

Estimated limits based on current volatility of 8.0%: low 1.48$, high 1.73$

Factors to consider:

  • Price in estimated range
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.04$, 3.78$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.07$, 3.27$]

Financial Metrics affecting the PROK estimates:

  • Negative: Non-GAAP EPS, $ of -0.57 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -44.90 <= 2.35
  • Negative: negative Net income
  • Negative: Investing cash flow per share, $ of -5.35 <= -3.48
  • Negative: 0 < Interest expense per share, $ of 0

Similar symbols

Short-term PROK quotes

Long-term PROK plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $55.11MM $153.01MM $151.52MM
Operating Income $-55.11MM $-153.01MM $-151.52MM
Non-Operating Income $0.00MM $5.77MM $22.07MM
Interest Expense $0.00MM $0.21MM $0.01MM
R&D Expense $46.26MM $82.07MM $106.71MM
Income(Loss) $-55.11MM $-147.24MM $-129.45MM
Taxes $0.04MM $0.90MM $6.00MM
Profit(Loss) $-55.15MM $-148.13MM $-135.45MM
Stockholders Equity $26.92MM $-1,096.62MM $-1,103.40MM
Assets $40.30MM $518.00MM $420.55MM
Operating Cash Flow $-50.30MM $-77.09MM $-90.07MM
Capital expenditure $5.19MM $1.85MM $34.20MM
Investing Cash Flow $-5.19MM $-1.74MM $-329.98MM
Financing Cash Flow $71.47MM $548.52MM $-9.55MM
Earnings Per Share* $-0.30 $-2.41 $-0.57

* EPS are Split Adjusted, recent splits may be reflected with a delay.